GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bal Pharma Ltd (NSE:BALPHARMA) » Definitions » Cash, Cash Equivalents, Marketable Securities

Bal Pharma (NSE:BALPHARMA) Cash, Cash Equivalents, Marketable Securities : ₹0 Mil (As of Dec. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Bal Pharma Cash, Cash Equivalents, Marketable Securities?

Bal Pharma's quarterly cash, cash equivalents, marketable securities increased from Jun. 2024 (₹0.00 Mil) to Sep. 2024 (₹261.56 Mil) but then stayed the same from Sep. 2024 (₹261.56 Mil) to Dec. 2024 (₹0.00 Mil).

Bal Pharma's annual cash, cash equivalents, marketable securities increased from Mar. 2022 (₹60.85 Mil) to Mar. 2023 (₹74.63 Mil) and increased from Mar. 2023 (₹74.63 Mil) to Mar. 2024 (₹199.29 Mil).


Bal Pharma Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Bal Pharma's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bal Pharma Cash, Cash Equivalents, Marketable Securities Chart

Bal Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.07 44.63 60.85 74.63 199.29

Bal Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 199.29 - 261.56 -

Bal Pharma Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Bal Pharma  (NSE:BALPHARMA) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Bal Pharma Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Bal Pharma's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Bal Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bal Pharma Ltd (NSE:BALPHARMA) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
Address
10/1, Palace Road, 5th Floor, Lakshmi Narayan Complex, Bengaluru, KA, IND, 560052
Bal Pharma Ltd is a pharmaceutical company. It is principally engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company specializes in prescription drugs, generic and over-the-counter products, intravenous infusion, and bulk actives. It offers products in dosage forms, such as tablets, capsules, syrups, suspensions, creams, and ointments, to various markets.

Bal Pharma Headlines

No Headlines